Nutrition
Zinc supplementation improves glucose homeostasis in patients with ß-thalassemia major complicated with diabetes mellitus: A randomized controlled trial.
Matter RM, Elbarbary NS, Ismail EAR, Darwish YW, Nada AS, Banoub VP
The development of abnormal glucose tolerance in ß-thalassemia major (ß-TM) is associated with alterations in the oxidant-antioxidant status. Zinc is ...
Read More
Source: PubMed
J Am Acad Child Adolesc Psychiatry 2020 Jan 30
Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization.
Blader JC, Pliszka SR, Kafantaris V, Foley CA, Carlson GA, Crowell JA, Bailey BY, Sauder C, Daviss WB, Sinha C, Matthews TL, Margulies DM
Stimulant medications are the most prevalent first-line pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD), but children with aggress ...
Read More
Source: PubMed
Br J Anaesth 2020 Jan 29
Effect of dexmedetomidine on acute kidney injury after aortic surgery: a single-centre, placebo-controlled, randomised controlled trial.
Soh S, Shim JK, Song JW, Bae JC, Kwak YL
Acute kidney injury (AKI) is a frequent and serious complication after aortic surgery requiring cardiopulmonary bypass (CPB). Dexmedetomidine, a selec ...
Read More
Source: PubMed
Chest 2020 Jan 29
Effects of the Combination of Atomoxetine and Oxybutynin on Obstructive Sleep Apnea Endotypic Traits.
Taranto-Montemurro L, Messineo L, Azarbarzin A, Vena D, Hess L, Calianese N, White DP, Wellman A, Sands S
We recently showed that the administration of the combination of the noradrenergic drug atomoxetine plus the antimuscarinic oxybutynin (ato-oxy) befor ...
Read More
Source: PubMed
Cochrane Database Syst Rev
Drug treatment for spinal muscular atrophy types II and III.
Wadman RI, van der Pol WL, Bosboom WM, Asselman FL, van den Berg LH, Iannaccone ST, Vrancken AF
Spinal muscular atrophy (SMA) is caused by a homozygous deletion of the survival motor neuron 1 (SMN1) gene on chromosome 5, or a heterozygous deletio ...
Read More
Source: PubMed
